Contact

All Stories

  1. Chronic pulmonary aspergillosis in children – a scoping global review

    Article • Open Forum Infectious Diseases, April 2026, Oxford University Press (OUP)

    Dr. Richard Kwizera

  2. False-Positive IMMY® Serum Cryptococcal Antigen Lateral Flow Assay Results Due to Improper Use of Titration Buffer

    Article • Journal of Fungi, February 2026, MDPI AG

    Dr. Richard Kwizera

  3. Pulmonary Aspergillosis treated with oral amphotericin B (MAT2203) in a patient with HIV-related Cryptococcal meningitis

    Article • January 2026, Wiley

    Dr. Richard Kwizera

  4. Burden of sickle cell anemia in Africa: A systematic review and meta-analysis

    Article • PLOS One, November 2025, PLOS

    Dr Gerald Mboowa, Dr. Richard Kwizera

  5. Pilot project demonstrating the feasibility of HIV antiretroviral therapy waste bottle collection and recycling

    Article • Wellcome Open Research, October 2025, Faculty of 1000, Ltd.

    Dr. Richard Kwizera

  6. Pilot project demonstrating the feasibility of HIV antiretroviral therapy waste bottle collection and recycling

    Article • Wellcome Open Research, October 2025, Faculty of 1000, Ltd.

    Dr. Richard Kwizera

  7. Regulatory Gaps in Over-the-Counter Antifungal Access for Vulvovaginal Candidiasis in Uganda: A Policy Analysis Framework

    Article • IJID Regions, September 2025, Elsevier

    Dr. Richard Kwizera

  8. Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-Week and 1-Year Survival Among Persons With HIV-Associated Cryptococcal Meningitis

    Article • The Journal of Infectious Diseases, August 2025, Oxford University Press (OUP)

    Dr. Richard Kwizera

  9. Antifungal susceptibility testing: applicability of methods and strategies for improving access in resource-constrained settings

    Article • The Lancet Infectious Diseases, December 2024, Elsevier

    Dr. Richard Kwizera

  10. Using single-dose liposomal amphotericin B for cryptococcal meningitis induction therapy: nurse pearls and practical perspectives

    Article • Wellcome Open Research, October 2024, Faculty of 1000, Ltd.

    Dr. Richard Kwizera

  11. A systematic review of fungi isolated from formalin-preserved human and animal cadavers: A potential health concern to exposed students and technicians

    Article • IJID One Health, September 2024, Elsevier

    Dr. Richard Kwizera

  12. Evolution of Laboratory Diagnostics for Cryptococcosis and Missing Links to Optimize Diagnosis and Outcomes in Resource-Constrained Settings

    Article • Open Forum Infectious Diseases, August 2024, Oxford University Press (OUP)

    Dr. Richard Kwizera

  13. Vaginal colonization with virulent and methicillin resistant Staphylococcus aureus among Ugandan women in Labour

    Article • BMC Microbiology, August 2024, Springer Science + Business Media

    Dr. Richard Kwizera

  14. Using single-dose liposomal amphotericin B for cryptococcal meningitis induction therapy: nurse pearls and practical perspectives

    Article • Wellcome Open Research, May 2024, Faculty of 1000, Ltd.

    Dr. Richard Kwizera

  15. Pilot project demonstrating the feasibility of HIV antiretroviral therapy waste bottle collection and recycling

    Article • Wellcome Open Research, April 2024, Faculty of 1000, Ltd.

    Dr. Richard Kwizera

  16. Re-estimation of the burden of serious fungal diseases in Uganda

    Article • Therapeutic Advances in Infectious Disease, January 2024, SAGE Publications

    Dr. Richard Kwizera

  17. Fungal diseases in Africa: Closing the gaps in diagnosis and treatment through implementation research and advocacy

    Article • Journal de Mycologie Médicale, November 2023, Elsevier

    Dr. Richard Kwizera

  18. Investigating Metabolic and Molecular Ecological Evolution of Opportunistic Pulmonary Fungal Coinfections: Protocol for a Laboratory-Based Cross-Sectional Study

    Article • JMIR Research Protocols, August 2023, JMIR Publications Inc.

    Dr. Richard Kwizera

  19. Prevalence of Histoplasma Antigenuria among Outpatient Cohort with Advanced HIV in Kampala, Uganda

    Article • Journal of Fungi, July 2023, MDPI AG

    Dr. Richard Kwizera

  20. Vaginal colonization with virulent Staphylococcus aureus and methicillin resistant Staphylococcus aureus among Ugandan women in labour

    Article • June 2023, Research Square

    Dr. Richard Kwizera

  21. Adherence of health workers to guidelines for screening and management of cryptococcal meningitis in Uganda

    Article • PLOS One, April 2023, PLOS

    Dr. Richard Kwizera

  22. Diagnostic options for pulmonary fungal diseases in Africa

    Article • ERJ Open Research, March 2023, European Respiratory Society (ERS)

    Dr. Richard Kwizera

  23. Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda

    Article • African Journal of Laboratory Medicine, February 2023, AOSIS Open Journals

    Dr. Richard Kwizera

  24. Improving mycetoma case detection through the training of community health workers in Northern Uganda: protocol for a stepped-wedge cluster-randomized trial

    Article • Therapeutic Advances in Infectious Disease, January 2023, SAGE Publications

    Dr. Richard Kwizera

  25. Invasive Fungal Diseases in Africa: A Critical Literature Review

    Article • Journal of Fungi, November 2022, MDPI AG

    Dr. Richard Kwizera

  26. Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda

    Article • African Health Sciences, October 2022, African Journals Online (AJOL)

    Dr. Richard Kwizera

  27. Medical Mycology dissertation topics require prioritisation among Postgraduate Microbiology trainees of Makerere University, Uganda

    Article • IJID Regions, June 2022, Elsevier

    Dr Gerald Mboowa, Dr. Richard Kwizera

  28. Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda

    Article • Mycoses, April 2022, Wiley

    Dr. Richard Kwizera

  29. Evaluation of the initial 12 months of a routine cryptococcal antigen screening program in reduction of HIV-associated cryptococcal meningitis in Uganda

    Article • BMC Health Services Research, March 2022, Springer Science + Business Media

    Dr. Richard Kwizera

  30. Rates of refusal of clinical autopsies among HIV-positive decedents and an overview of autopsies in Uganda

    Article • Wellcome Open Research, February 2022, Faculty of 1000, Ltd.

    Dr. Richard Kwizera

  31. Rates of refusal of clinical autopsies among HIV-positive decedents and an overview of autopsies in Uganda

    Article • Wellcome Open Research, November 2021, Faculty of 1000, Ltd.

    Dr. Richard Kwizera

  32. Mapping of Chronic Pulmonary Aspergillosis in Africa

    Article • Journal of Fungi, September 2021, MDPI AG

    Dr. Richard Kwizera

  33. Evaluation of the BioFire® FilmArray® Meningitis/Encephalitis panel in an adult and pediatric Ugandan population

    Article • Journal de Mycologie Médicale, September 2021, Elsevier

    Dr. Richard Kwizera

  34. Symptomatic Cryptococcal Meningitis with Negative Serum and Cerebrospinal Fluid Cryptococcal Antigen Tests

    Article • HIV/AIDS - Research and Palliative Care, September 2021, Taylor & Francis

    Dr. Richard Kwizera

  35. Surgical management of chronic pulmonary aspergillosis in Africa: A systematic review of 891 cases

    Article • Mycoses, August 2021, Wiley

    Dr. Richard Kwizera

  36. Evaluation of the Initial 12 Months of a Routine Cryptococcal Antigen Screening Program in Reduction of HIV-Associated Cryptococcal Meningitis in Uganda

    Article • August 2021, Research Square

    Dr. Richard Kwizera

  37. Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis

    Article • Journal of Clinical Microbiology, July 2021, ASM Journals

    Dr. Richard Kwizera

  38. Evaluation of an Aspergillus IgG/IgM lateral flow assay for serodiagnosis of fungal asthma in Uganda

    Article • PLOS One, May 2021, PLOS

    Dr. Richard Kwizera

  39. A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility

    Article • Science Translational Medicine, May 2021, American Association for the Advancement of Science

    Dr. Richard Kwizera

  40. Fungal asthma among Ugandan adult asthmatics

    Article • Medical Mycology, May 2021, Oxford University Press (OUP)

    Dr. Richard Kwizera

  41. Misdiagnosis of chronic pulmonary aspergillosis as pulmonary tuberculosis at a tertiary care center in Uganda: a case series

    Article • Journal of Medical Case Reports, March 2021, Springer Science + Business Media

    Dr. Richard Kwizera

  42. COVID-19 and the HIV care continuum in Uganda: minimising collateral damage

    Article • AAS Open Research, March 2021, Faculty of 1000, Ltd.

    Dr. Richard Kwizera

  43. Medical Mycology dissertation topics require prioritisation among Postgraduate Microbiology trainees of Makerere University, Uganda.

    Article • March 2021, Research Square

    Dr. Richard Kwizera

  44. Translational research in Uganda: linking basic science to bedside medicine in a resource limited setting

    Article • Journal of Translational Medicine, February 2021, Springer Science + Business Media

    Dr. Richard Kwizera

  45. Histoplasmosis overlapping with HIV and tuberculosis in sub-Saharan Africa: challenges and research priorities

    Article • Therapeutic Advances in Infectious Disease, January 2021, SAGE Publications

    Dr. Richard Kwizera

  46. Prevalence of Aspergillus fumigatus skin positivity in adults without an apparent/known atopic disease in Uganda

    Article • Therapeutic Advances in Infectious Disease, January 2021, SAGE Publications

    Dr. Richard Kwizera

  47. Estimation of the burden of tinea capitis among children in Africa

    Article • Mycoses, December 2020, Wiley

    Dr. Richard Kwizera

  48. Evaluation of the Dynamiker Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of HIV-Associated Cryptococcosis

    Article • Journal of Clinical Microbiology, December 2020, ASM Journals

    Dr. Richard Kwizera

  49. Deep fungal infections diagnosed by histology in Uganda: A 70-year retrospective study

    Article • International Journal of Infectious Diseases, December 2020, Elsevier

    Dr. Richard Kwizera

  50. Treatment of Histoplasmosis

    Article • September 2020, IntechOpen

    Dr. Richard Kwizera

  51. Impact of community engagement and social support on the outcomes of HIV-related meningitis clinical trials in a resource-limited setting

    Article • Research Involvement and Engagement, August 2020, Springer Science + Business Media

    Dr. Richard Kwizera

  52. COVID-19 and the HIV care continuum in Uganda: minimising collateral damage

    Article • AAS Open Research, July 2020, Faculty of 1000, Ltd.

    Dr. Richard Kwizera

  53. Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist

    Article • Journal of Fungi, June 2020, MDPI AG

    Dr. Richard Kwizera

  54. Intra-cavitary pulmonary cryptococcoma in poorly controlled diabetes mellitus

    Article • Medical Mycology Case Reports, June 2020, Elsevier

    Dr. Richard Kwizera

  55. Skin prick reactivity among asthmatics in East Africa

    Article • World Allergy Organization Journal, June 2020, Elsevier

    Dr. Richard Kwizera

  56. Erratum to “Online Learning Resources Enhanced Teaching and Learning of Medical Mycology among Medical Students in Gulu University, Uganda”

    Article • Education Research International, May 2020, Hindawi Publishing Corporation

    Dr. Richard Kwizera

  57. Mycetoma in Uganda: A neglected tropical disease

    Article • PLoS Neglected Tropical Diseases, April 2020, PLOS

    Dr. Richard Kwizera

  58. Deep fungal infections diagnosed by histology in Uganda: a 70-year retrospective study

    Article • Medical Mycology, April 2020, Oxford University Press (OUP)

    Dr. Richard Kwizera

  59. Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of Death

    Article • Journal of Clinical Medicine, March 2020, MDPI AG

    Dr. Richard Kwizera

  60. Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study

    Article • The Lancet Infectious Diseases, March 2020, Elsevier

    Dr. Richard Kwizera

  61. Online Learning Resources Enhanced Teaching and Learning of Medical Mycology among Medical Students in Gulu University, Uganda

    Article • Education Research International, January 2020, Hindawi Publishing Corporation

    Dr. Richard Kwizera

  62. Algorithm-aided diagnosis of chronic pulmonary aspergillosis in low- and middle-income countries by use of a lateral flow device

    Article • European Journal of Clinical Microbiology & Infectious Diseases, December 2019, Springer Science + Business Media

    Dr. Richard Kwizera

  63. Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patients

    Article • Wellcome Open Research, September 2019, Faculty of 1000, Ltd.

    Dr. Richard Kwizera

  64. Getting Histoplasmosis on the Map of International Recommendations for Patients with Advanced HIV Disease

    Article • Journal of Fungi, September 2019, MDPI AG

    Dr. Richard Kwizera

  65. Cor pulmonale complicating chronic pulmonary aspergillosis with fatal consequences: Experience from Uganda

    Article • Medical Mycology Case Reports, September 2019, Elsevier

    Dr. Richard Kwizera

  66. Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patients

    Article • Wellcome Open Research, August 2019, Faculty of 1000, Ltd.

    Dr. Richard Kwizera

  67. Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model

    Article • Open Forum Infectious Diseases, August 2019, Oxford University Press (OUP)

    Dr. Richard Kwizera

  68. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial

    Article • The Lancet Infectious Diseases, August 2019, Elsevier

    Dr. Richard Kwizera

  69. Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study

    Article • BMC Infectious Diseases, June 2019, Springer Science + Business Media

    Dr. Richard Kwizera

  70. Burden of fungal asthma in Africa: A systematic review and meta-analysis

    Article • PLOS One, May 2019, PLOS

    Dr. Richard Kwizera

  71. The conundrum of clinical trials and standard of care in sub-Saharan Africa – the research nurse perspective

    Article • Journal of Research in Nursing, March 2019, SAGE Publications

    Dr. Richard Kwizera

  72. Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis

    Article • Clinical Infectious Diseases, September 2018, Oxford University Press (OUP)

    Dr. Richard Kwizera

  73. Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis

    Article • BMC Pulmonary Medicine, November 2017, Springer Science + Business Media

    Dr. Richard Kwizera

  74. Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid

    Article • Medical Mycology, October 2017, Oxford University Press (OUP)

    Dr. Richard Kwizera

  75. Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis

    Article • BMC Microbiology, August 2017, Springer Science + Business Media

    Dr. Richard Kwizera

  76. Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients

    Article • PLOS One, July 2017, PLOS

    Dr. Richard Kwizera

  77. Cryptococcal disease and the burden of other fungal diseases in Uganda; Where are the knowledge gaps and how can we fill them?

    Article • Mycoses, October 2015, Wiley

    Dr. Richard Kwizera

  78. Evaluation of Fingerstick Cryptococcal Antigen Lateral Flow Assay in HIV-Infected Persons: A Diagnostic Accuracy Study: Figure 1.

    Article • Clinical Infectious Diseases, April 2015, Oxford University Press (OUP)

    Dr. Richard Kwizera

  79. Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model

    Article • Journal of Antimicrobial Chemotherapy, August 2014, Oxford University Press (OUP)

    Dr. Richard Kwizera

  80. Performance of Cryptococcal Antigen Lateral Flow Assay Using Saliva in Ugandans with CD4 <100

    Article • PLOS One, July 2014, PLOS

    Dr. Richard Kwizera

  81. Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast

    Article • Emerging Infectious Diseases, January 2014, Centers for Disease Control and Prevention (CDC)

    Dr. Richard Kwizera